These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8733757)

  • 1. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats.
    Hoffmann O; Wiesenfeld-Hallin Z
    Neuroreport; 1996 Feb; 7(3):838-40. PubMed ID: 8733757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
    Plesan A; Hedman U; Xu XJ; Wiesenfeld-Hallin Z
    Anesth Analg; 1998 Apr; 86(4):825-9. PubMed ID: 9539609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
    Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
    Bulka A; Wiesenfeld-Hallin Z; Xu XJ
    Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.
    Allen RM; Granger AL; Dykstra LA
    J Pharmacol Exp Ther; 2002 Feb; 300(2):435-41. PubMed ID: 11805202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
    Popik P; Kozela E; Danysz W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring.
    Tao PL; Yeh GC; Su CH; Wu YH
    Life Sci; 2001 Oct; 69(20):2439-50. PubMed ID: 11681630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
    Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
    Hoffmann O; Wiesenfeld-Hallin Z
    Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats.
    Plesan A; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Neurosci Lett; 1999 Mar; 263(1):53-6. PubMed ID: 10218909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways.
    Chow LH; Huang EY; Ho ST; Tsai SK; Tao PL
    J Biomed Sci; 2004; 11(6):717-25. PubMed ID: 15591767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
    Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
    Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.
    Singh L; Oles RJ; Field MJ; Atwal P; Woodruff GN; Hunter JC
    Br J Pharmacol; 1996 Jul; 118(5):1317-25. PubMed ID: 8818359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of dextromethorphan on the inhibitory effect of anti-NT4 on morphine tolerance.
    Hatami H; Oryan S; Semnanian S; Kazemi B; Ahmadiani A
    Pharmacology; 2006; 78(3):105-12. PubMed ID: 17003573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
    Holtman JR; Jing X; Wala EP
    Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.